Assure Holdings Corp. announces proposed public tender offer for common shares | New

DENVER, Aug. 19, 2022 (GLOBE NEWSWIRE) — Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company”), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced its intention to offer its common stock in the context of a public offer. The Company intends to use the net proceeds of this offering for general corporate purposes, including, but not limited to, working capital and other business opportunities. The Offer is subject to market conditions, and there can be no assurance whether or not the Offer will be completed, or as to the actual size or terms of the Offer.

Aegis Capital Corp. acts as sole bookrunner for the offering

This offering is made pursuant to an effective shelf registration statement on Form S-3 (No. 333-266730) previously filed with the United States Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on August 17, 2022. A prospectus supplement describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website at http://www.sec.gov. Electronic copies of the Prospectus Supplement may be obtained, when available, by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at [email protected] .com, or by phone at (212) 813-1010. Before investing in this offering, interested parties should read the Prospectus Supplement and the accompanying Prospectus in their entirety and the other documents the Company has filed with the SEC and which are incorporated by reference into this Supplement. prospectus and the accompanying prospectus, which provide more information about the Company and this offering.

This press release does not constitute an offer to sell or the solicitation of an offer to buy and there will be no sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of such state or territory.

About Assure Holdings

Assure Holdings Corp. is a provider of outsourced intraoperative neuromonitoring and remote neurology services. The company provides a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that put the nervous system at risk, including neurosurgery, spine, cardiovascular, orthopedic and surgeries ears, nose and throat. Assure Holdings employs highly trained technologists who provide a direct point of contact in the operating room. Physicians employed by Assure Holdings subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure by communicating in real time with the surgeon and technologist. Accredited by the Joint Commission, Assure Holdings’ mission is to provide exceptional surgical care and a positive patient experience.

Forward-looking statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain because they are based on current expectations and assumptions regarding future events or the future performance of the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating these statements, potential investors should carefully consider the various risks and uncertainties identified in this release and the matters set forth in the Company’s filings with the SEC. These risks and uncertainties could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements.

Contact

Scott Kozak, Investor and Media Relations

Assure Holdings Corp.

(720) 617-2526

[email protected]

Copyright 2022 GlobeNewswire, Inc.

Comments are closed.